Utilitzem cookies
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Ho sabíeu?
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Significats de incretin mimetics en anglès
Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes.
Sinònims
Examples for "glucagon-like peptide-1 agonist"
Examples for "glucagon-like peptide-1 agonist"
1
The acute intervention will consist of intravenous administration of the GLP-1 receptor agonist exenatide or placebo.
2
Our results indicate that inflammation and hypoxia in adipose tissue can be mitigated by GLP-1 receptor agonist potentially via improved angiogenesis and microcirculation in obesity.
3
The mechanisms underlying the weight-loss effect of GLP-1 receptor agonists need further elucidation.
4
GLP-1 receptor agonists, which mimic the effects of GLP-1, have been developed for the treatment of type 2 diabetes.
5
Here, we to determine whether sequence differences at the ligand C-termini of clinically approved GLP-1 receptor agonists exendin-4 and lixisenatide lead to similar phenomena.
Ús de incretin mimetics en anglès
1
The drugs are part of a class known as incretin mimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.
2
Both drugs are part of a class known as incretin mimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.
3
The diabetes medicines are part of a class known as incretin mimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.